Huntsworth’s (HNT) Buy Rating Reaffirmed at Peel Hunt

Huntsworth (LON:HNT)‘s stock had its “buy” rating reaffirmed by research analysts at Peel Hunt in a research note issued to investors on Monday, April 1st, ThisIsMoney.Co.Uk reports.

Shares of LON HNT traded up GBX 1.60 ($0.02) during trading on Monday, reaching GBX 86.80 ($1.13). The stock had a trading volume of 429,118 shares, compared to its average volume of 1,010,000. Huntsworth has a fifty-two week low of GBX 76.60 ($1.00) and a fifty-two week high of GBX 140 ($1.83). The company has a current ratio of 1.46, a quick ratio of 1.29 and a debt-to-equity ratio of 50.92. The stock has a market capitalization of $310.78 million and a PE ratio of 14.23.

About Huntsworth

Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams.

See Also: How do buyers and sellers choose a strike price?

Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.